Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Schering-Plough Canada finds defect in Pegetron cartridges

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Health Canada.Important information regarding the quality, safety and supply of PEGETRON (Rm) (ribavirin 200 mg Capsules plus peginterferon alfa-2b Powder for Solution in REDIPEN (Rm) Single dose Delivery System: 80 mcg per 0.5 mL, 100 mcg per 0.5 mL, 120 mcg per 0.5 mL and 150 mcg per 0.5 mL). Internet Document: [3 pages], 4 Oct 2010. Available from: URL: http://www.hc-sc.gc.ca

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Schering-Plough Canada finds defect in Pegetron cartridges. React. Wkly. 1324, 2 (2010). https://doi.org/10.2165/00128415-201013240-00002

    Download citation

    Keywords

    • Hepatitis
    • Delivery System
    • Chronic Hepatitis
    • Health Care Professional
    • Injection Site